These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 14961168

  • 1. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J, Siegbahn A, Grip L, Linder R, Thygesen K, Wallentin L.
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [Abstract] [Full Text] [Related]

  • 2. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
    Oldgren J, Linder R, Grip L, Siegbahn A, Wallentin L.
    Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Coagulation activity and clinical outcome in unstable coronary artery disease.
    Oldgren J, Linder R, Grip L, Siegbahn A, Wallentin L.
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
    [Abstract] [Full Text] [Related]

  • 7. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD.
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease.
    Oldgren J, Fellenius C, Boman K, Jansson JH, Nilsson TK, Wallentin L, Siegbahn A.
    J Intern Med; 2005 Nov; 258(5):420-7. PubMed ID: 16238677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.
    Circulation; 2004 Nov 16; 110(20):3206-12. PubMed ID: 15533869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators.
    Circulation; 2008 Aug 05; 118(6):632-8. PubMed ID: 18645057
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun 05; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.